Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions: Metastatic Breast Cancer; Triple Negative Breast Cancer; Estrogen-receptor-low Breast Cancer Interventions: Drug: Carboplatin; Drug: Tocilizumab Sponsors: Kathy Miller; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions: Aneurysm; Behcet Syndrome, Vascular Type Interventions: Drug: tocilizumab; Drug: tofacitinib; Drug: cyclophosphamide Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions: Metastatic Breast Cancer; Triple Negative Breast Cancer; Estrogen-receptor-low Breast Cancer Interventions: Drug: Carboplatin; Drug: Tocilizumab Sponsors: Kathy Miller; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions: Aneurysm; Behcet Syndrome, Vascular Type Interventions: Drug: tocilizumab; Drug: tofacitinib; Drug: cyclophosphamide Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers
Conditions: Metastatic Breast Cancer; Triple Negative Breast Cancer; Estrogen-receptor-low Breast Cancer Interventions: Drug: Carboplatin; Drug: Tocilizumab Sponsors: Kathy Miller; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
Tocilizumab and Tofacitinib in the Treatment of Vascular Beh çet's Syndrome
Conditions: Aneurysm; Behcet Syndrome, Vascular Type Interventions: Drug: tocilizumab; Drug: tofacitinib; Drug: cyclophosphamide Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2023 Category: Research Source Type: clinical trials
A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus Interventions: Drug: RO7507062; Drug: Tocilizumab Sponsor: Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Conditions: Mantle Cell Lymphoma; Mantle Cell Lymphoma Refractory Interventions: Drug: Glofitamab; Drug: Pirtobrutinib; Drug: Obinutuzumab; Drug: Tocilizumab Sponsor: Australasian Leukaemia and Lymphoma Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
